PR Newswire
22 Dec 2022, 21:36 GMT+10
WELLINGTON, New Zealand, Dec. 22, 2022 /PRNewswire/ -- P3 Research, a leading New Zealand clinical trials site network with seven locations across New Zealand has taken on healthcare specialist private equity firm Genesis Capital as an investor.
P3 is one of New Zealand's largest clinical trials site networks focused on recruitment excellence, high-quality data and streamlined processes in phase two and three trials for global pharmaceutical sponsors and CROs. With its significant site network, P3 is well known amongst sponsors for its ability to provide patient recruitment from a diverse cross-section of the country, while also granting New-Zealanders across the country access to medications that would otherwise be difficult to find or expensive.
The investment builds on Genesis's backing earlier in the year into bioanalytical laboratory Crux Biolabs, as part of continued focus by the fund on high-potential clinical trials services businesses in Australia and New Zealand,
Professor Richard Stubbs, CEO of P3 Research said, "New Zealand has become increasingly a destination of choice for the global clinical trials industry. With Genesis now on board, we look forward to being able to further expand our high-quality service capability with new sites catering to new and expanded therapeutic areas for our clients, while increasing patient access to the latest ground-breaking therapies across a broad range of disease states."
The contract research sector has seen accelerated growth across the region in recent years thanks in part to the importance placed on community-based trials such as those conducted at P3 clinics for bringing breakthroughs quickly to the global market.
Alongside expansion plans, the investment from Genesis will also focus on enhancing technological and patient recruitment capabilities for P3 to further cater to the increased global demand from CROs and sponsors in need of high-quality clinical trials.
Michael Caristo, partner at Genesis Capital said "The pandemic has highlighted the crucial need for these kinds of organisations in propelling medical advancements forward at the pace needed to have impact at a global scale. P3 Research has been the go-to for leading clinical trials for almost two decades in New Zealand and we're excited about being a part of their next phase of growth."
Genesis Capital was advised by Harmos Horton Lusk for legal and EY for accounting.
About P3 Research
P3 Research is a leading and respected independent clinical trials company dedicated to performing high quality clinical studies on behalf of worldwide pharmaceutical companies, contract research organisations and individual researchers.
About Genesis Capital
https://genesiscapital.com.au/
Genesis Capital is a specialist investment firm focused on building strong healthcare businesses in Australia and New Zealand. They are an active partner working alongside management to unlock growth in healthcare businesses that have the potential to be industry leaders.
Get a daily dose of Sydney Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Sydney Sun.
More InformationBANGKOK, Thailand: Following China's reopening and the end of its strict COVID-19 restrictions, businesses on Thailand's holiday island of Phuket ...
NEW YORK, New York - Recession fears faded on Wall Street Thursday as annualized 4th quarter GDP (gross domestic product) ...
WASHINGTON D.C.: In December 2022, US existing home sales declined to a 12-year low, but lower mortgage rates raised cautious ...
SEOUL, South Korea: Korea Customs Service data released this week showed that South Korean exports for the first 20 days ...
SEATTLE, Washington: Amazon.com's cloud services division, Amazon Web Services (AWS), has announced that it will expand its data centers in ...
NEW YORK, New York - U.S. stocks crumbled on Wednesday as the extended rally on Wall Street came to an ...
TOKYO, Japan: Japanese Prime minister Fumio Kishida said this week that it was "now or never" for Japan, one of ...
WASHINGTON D.C.: As part of its efforts to simplify the national COVID-19 vaccine strategy, the US Food and Drug Administration ...
WASHINGTON D.C.: US authorities said this week that a surge in Cubans and Nicaraguans arriving at the US border with ...
OTTAWA, Canada: Canadian Prime Minister Justin Trudeau's Liberal government plans to implement its long-awaited workforce transition bill, the "Just Transition," ...
TOKYO, Japan: The Yomiuri newspaper has reported that Japanese Prime Minister Fumio Kishida is planning to visit Kyiv in February ...
HONOLULU, Hawaii: The casket bearing Abigail Kinoiki Kekaulike Kawananakoa, long considered the last Hawaiian princess, has gone on public viewing ...